• Episode 5: Professor Roger Greenhalgh

  • Apr 6 2022
  • Length: 1 hr and 2 mins
  • Podcast

Episode 5: Professor Roger Greenhalgh By cover art

Episode 5: Professor Roger Greenhalgh

Listen for free

View show details

  • Summary

  • Professor Roger Greenhalgh has been instrumental in defining when and how to treat aortic aneurysm disease, through decades of clinical trial research that has led that line of scientific inquiry. Such trials include the UK Small Aneurysms trial, EVAR 1, EVAR 2 and IMPROVE which together have formed the foundational evidence for clinical practice guidelines. This interview includes the back story of how they came to be, as well as exploring the world-famous Charing Cross Symposium, now in its 44th year, which has had to reinvent itself in the face of the COVID-19 pandemic. Roger also shares many wonderfully entertaining personal anecdotes in this most delightful interview.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Show more Show less

What listeners say about Episode 5: Professor Roger Greenhalgh

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available